YEDA RES AND DEVELOPMENT COMPANY LTD has a total of 14 patent applications. Its first patent ever was published in 1963. It filed its patents most often in Norway, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BACHOVCHIN WILLIAM W, BIOEXPERTISE LLC and ZEALAND PHARMA A.
# | Country | Total Patents | |
---|---|---|---|
#1 | Norway | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Brazil | 2 | |
#4 | Australia | 1 | |
#5 | China | 1 | |
#6 | Spain | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Measurement | |
#6 | Materials and metallurgy |
# | Name | Total Patents |
---|---|---|
#1 | Scherz Avigdor | 4 |
#2 | Salomon Yoram | 4 |
#3 | Eren Doron | 3 |
#4 | Brandis Alexander | 3 |
#5 | Ramakrishnan Parameswaran | 2 |
#6 | Cohen Avraham | 2 |
#7 | Wallach David | 2 |
#8 | Eisenbach-Schwartz Michal | 1 |
#9 | Cohen Hagai | 1 |
#10 | Alioshin Yury | 1 |
Publication | Filing date | Title |
---|---|---|
US2018305405A1 | Conjugates of RGD peptides and (bacterio)chlorophyll photosensitizers | |
CN108025068A | Systemic regulatory T cells level or activity is reduced to treat the disease of CNS and damage |